The abstract is read at the publisher; the summary is JClub's.
Cryo-EM structures show the Mycobacterium tuberculosis DprE1–DprE2 epimerase complex assembles as a membrane-associated tetramer, enabling drug binding across DprE1 and DprE2.
- Why it matters: Pretomanid and delamanid target DprE2 and quabodepistat targets DprE1, but how the DprE1–DprE2 complex works and how these compounds inhibit it was unclear.
- What they did: The authors solved cryo-EM structures of the DprE1–DprE2 complex with substrate or quabodepistat in DprE1, and with activated pretomanid or delamanid in DprE2.
- The result: Pretomanid and delamanid bind DprE2 as NADH-adducts in a pocket spanning the NADH- and substrate-binding sites, while quabodepistat binds DprE1 uniquely, informing rational derivative design.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.